DCE MRI
DCE MRI is a medical procedure with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
Foot Perfusion by Dynamic Contrast Enhanced MRI in Patients With Peripheral Artery Disease
Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body
Perfusion and Diffusion Magnetic Resonance Imaging, and Phosphorylation of Circulation Endothelial Cells to Determine Anti-anogenic Effect of Chemotherapeutic Regimens in Colorectal Liver Metastasis Patients
Clinical Trials (6)
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
Foot Perfusion by Dynamic Contrast Enhanced MRI in Patients With Peripheral Artery Disease
Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body
Perfusion and Diffusion Magnetic Resonance Imaging, and Phosphorylation of Circulation Endothelial Cells to Determine Anti-anogenic Effect of Chemotherapeutic Regimens in Colorectal Liver Metastasis Patients
Noninvasive Surrogate Marker for Advanced Hepatocellular Carcinoma Response to Concurrent Chemoradiotherapy: MR Perfusion, Contrast Enhanced Ultrasound and Biomarkers
All 6 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 6